Skip to content

SANGAMO THERAPEUTICS, INC

SGMOQ · OTCM

CIK 1001233fmd_0PA2E3EMHH7T13ZPF8XFE3K3Q7Manufacturing · Biological Products, (No Diagnostic Substances)Template: Standard

Coverage: Jan 01, 2009 to Mar 31, 2026, 65 periods

News summary

An AI model writes the summary on request, from this company's recent filings only, and cites each filing it uses.

AI-written
0 filings

From 8-K filings, not wire news: the items each filer selected on the EDGAR cover, grouped by event type. Importance is FinancialMD's own rule by item number (5: bankruptcy, non-reliance, change of control, delisting, cybersecurity; 1: exhibits only).

Loading